Suppr超能文献

胃黏膜相关淋巴组织淋巴瘤与幽门螺杆菌感染:来自哥伦比亚的观点。

Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective.

机构信息

Institute of Genetics, Universidad Nacional de Colombia, 14490 Bogotá DC, Colombia.

出版信息

World J Gastroenterol. 2012 Feb 21;18(7):685-91. doi: 10.3748/wjg.v18.i7.685.

Abstract

AIM

To assess the significance of chromosome translocation t(11;18)(q21;q21), B-cell lymphoma 10 (BCL-10) protein and Helicobacter pylori (H. pylori) infection in gastric mucosa-associated lymphoid tissue (MALT) lymphoma in Colombia.

METHODS

Fifty cases of gastric MALT lymphoma and their respective post-treatment follow-up biopsies were examined to assess the presence of the translocation t(11;18)(q21;q21) as identified by fluorescence in situ hybridization; to detect protein expression patterns of BCL10 using immunohistochemistry; and for evaluation of tumor histology to determine the correlation of these factors and resistance to H. pylori eradication.

RESULTS

Infection with H. pylori was confirmed in all cases of gastric MALT lymphoma in association with chronic gastritis. Bacterial eradication led to tumor regression in 66% of cases. The translocation t(11;18)(q21;q21) was not present in any of these cases, nor was there evidence of tumor transformation to diffuse large B-cell lymphoma. Thirty-four percent of the patients showed resistance to tumor regression, and within this group, 7 cases, representing 14% of all those analyzed, were considered to be t(11;18)(q21;q21)-positive gastric MALT lymphomas. Protein expression of BCL10 in the nucleus was associated with the presence of translocation and treatment resistance. Cases that were considered unresponsive to therapy were histologically characterized by the presence of homogeneous tumor cells and a lack of plasmacytic differentiation. Responder cases exhibited higher cellular heterogeneity and a greater frequency of plasma cells.

CONCLUSION

Both t(11;18)(q21;q21)-positive MALT lymphoma cases and those with nuclear BCL10 expression are considered resistant to H. pylori eradication. It is suggested that chronic antigenic stimulation is not a dominant event in resistant cases.

摘要

目的

评估染色体易位 t(11;18)(q21;q21)、B 细胞淋巴瘤 10 蛋白(BCL-10)和幽门螺杆菌(H. pylori)感染在哥伦比亚胃黏膜相关淋巴组织(MALT)淋巴瘤中的意义。

方法

对 50 例胃 MALT 淋巴瘤及其相应的治疗后随访活检进行检查,以评估荧光原位杂交法检测到的易位 t(11;18)(q21;q21)的存在;使用免疫组织化学检测 BCL10 蛋白的表达模式;评估肿瘤组织学,以确定这些因素与 H. pylori 根除治疗耐药性的相关性。

结果

所有胃 MALT 淋巴瘤病例均证实存在 H. pylori 感染,同时伴有慢性胃炎。细菌根除导致 66%的病例肿瘤消退。这些病例均未出现易位 t(11;18)(q21;q21),也未发现肿瘤转化为弥漫性大 B 细胞淋巴瘤。34%的患者出现肿瘤消退耐药,在这一组中,有 7 例(占所有分析病例的 14%)被认为是 t(11;18)(q21;q21)阳性胃 MALT 淋巴瘤。核内 BCL10 蛋白的表达与易位和治疗耐药性有关。被认为对治疗无反应的病例在组织学上表现为肿瘤细胞均匀,缺乏浆细胞分化。有反应的病例表现出更高的细胞异质性和更高的浆细胞频率。

结论

t(11;18)(q21;q21)阳性 MALT 淋巴瘤病例和核内 BCL10 表达阳性病例均被认为对 H. pylori 根除治疗耐药。这表明在耐药病例中,慢性抗原刺激不是主要事件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验